453
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Validation of overall survival extrapolations made by TLV in the assessment of cost-effectiveness of oncology drugs in Sweden – A pilot study comparing extrapolated and observed life-years gained

, , & ORCID Icon
Pages 193-200 | Received 22 Dec 2023, Accepted 09 Jan 2024, Published online: 29 Jan 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.